Press Releases and Adhoc Announcements 2018

Friday, 02 November 2018 06:57

PM: Heidelberg Pharma Announces Several Presentations of Research Results on ATAC Technology at the ASH Annual Meeting 2018

Thursday, 11 October 2018 12:03

AH: Partner Magenta Therapeutics Exercises Option To Further Develop a Target Molecule as Antibody Targeted Amanitin Conjugate

Thursday, 11 October 2018 07:28

PR: Heidelberg Pharma AG: Interim management statement on the first nine months of 2018

Thursday, 23 August 2018 10:44

PR: Heidelberg Pharma AG: Partner Telix Pharmaceuticals Files Phase III Trial for Kidney Cancer Imaging in Europe

Thursday, 12 July 2018 07:10

PR: Heidelberg Pharma reports on first half-year

Tuesday, 26 June 2018 14:14

PR: Heidelberg Pharma Reports Outcome Of Annual General Meeting

Monday, 30 April 2018 11:32

PR: Heidelberg Pharma Presents at Upcoming Conferences and Investor Events

Thursday, 12 April 2018 06:57

Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2018

Monday, 09 April 2018 08:41

PM: Heidelberg Pharma Presents Proprietary ATAC Technology Platform at Two Scientific Conferences

Thursday, 22 March 2018 07:05

PM: Heidelberg Pharma announces financial figures for fiscal year 2017 and provides business update

Monday, 05 March 2018 15:18

PR: Heidelberg Pharma and Magenta Therapeutics Sign Exclusive Multi-Target Research Agreement for the Development of Antibody Drug Conjugates

Monday, 05 March 2018 14:40

AH: Heidelberg Pharma and Magenta Therapeutics Sign Exclusive Multi-Target Research Agreement for the Development of Antibody Drug Conjugates

Thursday, 01 March 2018 09:00

PR: Heidelberg Pharma Signs License Agreement with The University of Texas MD Anderson Cancer Center

Monday, 08 January 2018 13:40

PR: Heidelberg Pharma AG and Advanced Proteome Therapeutics Progress Collaborative Program

Cookies make it easier for us to provide you with our services. With the usage of our services you permit us to use cookies.